Attached files
file | filename |
---|---|
S-1/A - S-1/A AMENDMENT NO.3 - Magenta Therapeutics, Inc. | d549494ds1a.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Magenta Therapeutics, Inc.:
We consent to the use of our report included herein and to the reference to our firm under the heading Experts in the prospectus.
/s/ KPMG LLP
Cambridge, Massachusetts
June 18, 2018